Pharmatest will participate in ASBMR Annual Meeting 2024

Pharmatest will participate in ASBMR Annual Meeting 2024 and Rare Bone Disease Symposium on Exploring and Expanding Treatments and Analytical Tools in Rare Bone Diseases, September 26-30 in Toronto!

We will present a poster “Effects of Anabolic Treatments with Teriparatide and Romosozumab on Bone in +/G610C Mouse Model of Adult Osteogenesis Imperfecta” with presentation numbers Sat-183 (ASBMR) and PM-116 (Rare Bone Diseases).

Let us know if you would like to discuss how Pharmatest could help you with your research.

ASBMR2024
rarediseases
bonediseases
CRO
preclinicalresearch